|
CA2511013A1
(en)
|
2002-12-20 |
2004-07-15 |
Biogen Idec Ma Inc. |
Multivalent lymphotoxin beta receptor agonists and therapeutic uses thereof
|
|
JP2006513225A
(ja)
|
2002-12-20 |
2006-04-20 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
化学療法剤と組み合わせたリンホトキシンβ受容体因子
|
|
NZ543635A
(en)
|
2003-06-25 |
2008-05-30 |
Crucell Holland Bv |
Human C-type lectin: a suitable target molecule for binding molecules, particularly immunoconjugates, in the diagnosis, prevention and/or treatment of myeloid neoplastic diseases such as AML and CML
|
|
US7803376B2
(en)
|
2003-07-24 |
2010-09-28 |
Innate Pharma S.A. |
Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compounds
|
|
CA2533753C
(en)
|
2004-03-19 |
2012-10-16 |
Morinaga Milk Industry Co., Ltd. |
Drug for cancer therapy
|
|
CA2600505C
(en)
|
2005-03-10 |
2016-05-03 |
Morphotek, Inc. |
Anti-mesothelin antibodies
|
|
US8993295B2
(en)
|
2006-07-20 |
2015-03-31 |
The General Hospital Corporation |
Methods, compositions, and kits for the selective activation of protoxins through combinatorial targeting
|
|
EP2111550B1
(en)
|
2007-01-26 |
2011-11-30 |
University Of Louisville Research Foundation, Inc. |
Methods of detecting autoantibodies for diagnosing and characterizing disorders
|
|
EP2014680A1
(en)
|
2007-07-10 |
2009-01-14 |
Friedrich-Alexander-Universität Erlangen-Nürnberg |
Recombinant, single-chain, trivalent tri-specific or bi-specific antibody derivatives
|
|
EP2197909A4
(en)
|
2007-08-24 |
2014-12-03 |
Univ Minnesota |
REAGENTS ON RECIPES
|
|
EP2332994A1
(en)
|
2009-12-09 |
2011-06-15 |
Friedrich-Alexander-Universität Erlangen-Nürnberg |
Trispecific therapeutics against acute myeloid leukaemia
|
|
UY33492A
(es)
|
2010-07-09 |
2012-01-31 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
|
WO2012017522A1
(ja)
|
2010-08-03 |
2012-02-09 |
富士通株式会社 |
検証プログラムおよび検証装置
|
|
CN107880136B
(zh)
|
2010-09-21 |
2021-11-12 |
阿尔托生物科学有限公司 |
多聚体il-15可溶性融合分子与其制造与使用方法
|
|
CN102251013A
(zh)
|
2011-02-22 |
2011-11-23 |
北京市肿瘤防治研究所 |
一个识别肿瘤起始细胞的抗体和抗原及其应用
|
|
SG195253A1
(en)
|
2011-06-03 |
2013-12-30 |
Xoma Technology Ltd |
Antibodies specific for tgf-beta
|
|
EP2537933A1
(en)
|
2011-06-24 |
2012-12-26 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
An IL-15 and IL-15Ralpha sushi domain based immunocytokines
|
|
WO2013039883A1
(en)
|
2011-09-12 |
2013-03-21 |
Abbvie Biotherapeutics Inc. |
Artificial nk cells and uses thereof
|
|
WO2013163427A1
(en)
|
2012-04-25 |
2013-10-31 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Antibodies to treat hiv-1 infection
|
|
EP3470431A1
(en)
|
2012-09-27 |
2019-04-17 |
Merus N.V. |
Bispecific igg antibodies as t cell engagers
|
|
EP3447072A3
(en)
|
2013-03-05 |
2019-05-22 |
Baylor College of Medicine |
Engager cells comprising cd3 scfv and an antigen recognition domain that binds a tumor antigen for immunotherapy
|
|
US9879081B2
(en)
|
2013-06-25 |
2018-01-30 |
Samsung Electronics Co., Ltd. |
Protein complex, bispecific antibody including the protein complex, and method of preparation thereof
|
|
US10287354B2
(en)
|
2013-12-20 |
2019-05-14 |
Novartis Ag |
Regulatable chimeric antigen receptor
|
|
EP3593812A3
(en)
*
|
2014-03-15 |
2020-05-27 |
Novartis AG |
Treatment of cancer using chimeric antigen receptor
|
|
KR20170037625A
(ko)
|
2014-07-21 |
2017-04-04 |
노파르티스 아게 |
Cll-1 키메라 항원 수용체를 사용한 암의 치료
|
|
US20180021378A1
(en)
|
2014-12-31 |
2018-01-25 |
Anthrogenesis Corporation |
Methods of treating hematological disorders, solid tumors, or infectious diseases using natural killer cells
|
|
EP3310378B1
(en)
|
2015-06-16 |
2024-01-24 |
F. Hoffmann-La Roche AG |
Anti-cll-1 antibodies and methods of use
|
|
MX389194B
(es)
|
2015-10-06 |
2025-03-20 |
Univ Minnesota |
Compuestos terapéuticos y métodos.
|
|
WO2017125897A1
(en)
|
2016-01-21 |
2017-07-27 |
Novartis Ag |
Multispecific molecules targeting cll-1
|
|
CA3055200A1
(en)
*
|
2017-03-03 |
2018-09-07 |
Obsidian Therapeutics, Inc. |
Compositions and methods for immunotherapy
|
|
SG11202002298PA
(en)
|
2017-09-14 |
2020-04-29 |
Dragonfly Therapeutics Inc |
Proteins binding nkg2d, cd16, and c-type lectin-like molecule-1 (cll-1)
|
|
WO2019246593A2
(en)
*
|
2018-06-22 |
2019-12-26 |
Fred Hutchinson Cancer Research Center |
Compositions and methods to target cll-1 and cd123 for the treatment of acute myeloid leukemia and related disorders
|